ARCHIVES

NCI Announces New CREG Offer For In Vitro Chemical Carcinogenesis Tests

This article is from The Cancer Letter archive.

Vol. 01 No. 47 | November 21, 1975

Download PDF Visit The Full Archive

Related Articles

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

NCI-Approved Protocols Listed

March 28, 2003

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

In Brief: Schilsky Succeeds McIntyre As CALB Chair; UC Irvine Awarded New Cancer Center Grants

November 11, 1994

Amgen, J&J Defend ESA Indications.

March 21, 2008

Secondary AML In High-Dose Chemo Trial Cause For Careful Monitoring, NCI Says

August 19, 1994